Company: SGBAF
Filing Date: 2025-01-17
Form Type: DRS/A
Source: 0000950123-25-000378
Chunk: 428

Company: SES S.A.
Filing Date: 2025-01-17
Form: DRS/A
Chunk 428
---
 of the Company and the holders of restricted stock units
pursuant to the terms of the relevant award agreements, on the relevant record date. On September 27, 2024, the Company paid $7.07 per outstanding share to its common shareholders of record at the close of business on September 17, 2024. Payments
will be made to holders of restricted stock units pursuant to the terms of the relevant award agreements upon vesting of the underlying restricted stock units.

IS-33e Satellite Anomaly

In
October 2024, Intelsat 33e experienced an anomaly that caused a total loss of the satellite. A failure review board has been convened with the satellite’s manufacturer, Boeing Satellite Systems, Inc., to complete a comprehensive analysis of the
cause of the anomaly. While our review of the full financial impact of the satellite failure is still not complete, we expect to record an impairment charge in the fourth quarter of 2024 of approximately $97 million. The fourth quarter charge may
include other financial impacts. We are actively migrating customers from Intelsat 33e to other satellites in our network, as well as third-party services, which may result in the incurrence of additional operating expenses during the remainder of
2024.

F-161

Confidential Treatment Requested by SES

Pursuant to 17 C.F.R. Section 200.83

SUPPLEMENTARY INFORMATION

F-162

Confidential Treatment Requested by SES Pursuant to 17 C.F.R. Section 200.83 Supplemental Consolidating Financial Information The following presents our unaudited condensed consolidating balance sheet as of December 31, 2023 and unaudited condensed consolidating statements of operations, changes in shareholders’ equity and cash flows for the year ended December 31, 2023. Investments in subsidiaries in the following unaudited condensed consolidating financial information are accounted for under the equity method of accounting. Consolidating adjustments include eliminations of the following:

| • |     | investments in subsidiaries; |

| • |     | intercompany accounts; |

| • |     | intercompany sales and expenses; and |

| • |     | intercompany equity balances. |

F-163

Confidential Treatment Requested by SES Pursuant to 17 C.F.R. Section 200.83 INTELSAT S.A. AND SUBSIDIARIES UNAUDITED CONDENSED CONSOLIDATING BALANCE SHEET AS OF DECEMBER 31,